- Home
- DSGX vs ZLAB Comparison
DSGX vs ZLAB Comparison
Compare DSGX & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSGX | ZLAB |
|---|---|---|
| Founded | 1981 | 2013 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 2.0B |
| IPO Year | 1999 | 2017 |
Fundamental Metrics
Financial Performance| Metric | DSGX | ZLAB |
|---|---|---|
| Price | $89.31 | $18.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $119.40 | $57.22 |
| AVG Volume (30 Days) | 475.2K | ★ 937.7K |
| Earning Date | 12-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.65 | N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $703,706,000.00 | $441,629,000.00 |
| Revenue This Year | $11.82 | $26.16 |
| Revenue Next Year | $11.25 | $30.62 |
| P/E Ratio | $50.03 | ★ N/A |
| Revenue Growth | 11.39 | ★ 24.14 |
| 52 Week Low | $78.88 | $16.82 |
| 52 Week High | $124.31 | $44.34 |
Technical Indicators
Market Signals| Indicator | DSGX | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 51.44 | 39.22 |
| Support Level | $88.36 | $17.37 |
| Resistance Level | $90.22 | $19.01 |
| Average True Range (ATR) | 1.60 | 0.62 |
| MACD | -0.09 | 0.30 |
| Stochastic Oscillator | 15.31 | 51.53 |
Price Performance
Historical ComparisonAbout DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.